Photobiomodulation for Oral Mucositis – A Microcosting and Budget Impact Analysis from a Brazilian Perspective

Paula Maria Maracajá Bezerra; Thayana Maria Navarro Ribeiro de Lima; Ana Beatriz Rodrigues Moura; Ana Maria Gondim Valença; Edson Hilan Gomes de Lucena; Yuri Wanderley Cavalcanti; Simone Alves de Sousa

Authors

Paula Maria Maracajá Bezerra
Thayana Maria Navarro Ribeiro de Lima
Ana Beatriz Rodrigues Moura
Ana Maria Gondim Valença
Edson Hilan Gomes de Lucena
Yuri Wanderley Cavalcanti
Simone Alves de Sousa

Keywords:

Low-Level Light Therapy, Stomatitis, Oncology Service, Hospital, Models, Economic

Abstract

Objective: To measure the costs of preventive and therapeutic protocols of Photobiomodulation (PBM) for oral mucositis (OM) and their budgetary impact on Brazil’s Ministry of Health (BMH). Material and Methods: A partial economic analysis was performed to estimate the costs using a bottom-up approach from a social perspective. Monetary values were assigned in Brazilian reais (BRL). The costs of the preventive protocol were calculated for five, 30, and 33 consecutive PBM sessions, depending on the antineoplastic treatment instituted. The costs of the therapeutic protocol were calculated for 5 or 10 sessions. The annual financial and budgetary impact was calculated considering the groups of oncologic patients with a higher risk of development of OM, such as those with head and neck and hematological cancer and pediatric patients. Results: The cost of a PBM session was estimated at BRL 23.75. The financial impact of providing one preventive protocol per year for all oncologic patients would be BRL 14,282,680.00, 0.030% of the estimated budget for hospital and outpatient care of the BMH in 2022. The financial and budgetary impacts of providing one treatment for OM for all patients in one year would be BRL 2,225,630.31 (0.005%, most optimistic scenario) and BRL 4,451,355.63 (0.009%, most pessimistic scenario). Conclusion: The budgetary impact of implementing PBM protocols in the Brazilian Healthcare System is small, even in a pessimistic scenario.

References

Instituto Nacional do Câncer. José Alencar Gomes da Silva. Estimativa 2016: incidência de câncer no Brasil. Rio de Janeiro: INCA, 2015. 122p. [In Portuguese].

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3):209-249. https://doi.org/10.3322/caac.21660

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer 2021; 149:778-789. https://doi.org/10.1002/ijc.33588

Curra M, Soares Junior LAV, Martins MD, Santos PSDS. Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein 2018; 16(1):eRW4007. https://doi.org/10.1590/s1679-45082018rw4007

Ritwik P. Dental care for patients with childhood cancers. Ochsner J 2018; 18(4):351-357. https://doi.org/10.31486/toj.18.0061

McCullough RW. US oncology-wide incidence, duration, costs and deaths from chemoradiation mucositis and antimucositis therapy benefits. Future Oncol 2017; 13(30):2823-2852. https://doi.org/10.2217/fon-2017-0418

Ribeiro ILA, de Castro RD, Costa RC, Damascena LCL, de Lucena NNN, Maracajá PMB, et al. Integrated oral care contributes positively to the course of treatment of oncopediatric patients. Eur J Pediatr 2021; 180(9):2757-2764. https://doi.org/10.1007/s00431-021-04024-z

Mallick S, Benson R, Rath GK. Radiation-induced oral mucositis: a review of current literature on prevention and management. Eur Arch Otorhinolaryngol 2016; 273(9): 2285-2293. https://doi.org/10.1007/s00405-015-3694-6

Figueiredo ALP, Lins L, Cattony AC, Falcão AFP. Laser therapy in the control of oral mucositis: A meta-analysis. Rev Assoc Med Bras 2013; 59(5):467-474. https://doi.org/10.1016/j.ramb.2013.08.003

Jadaud E, Bensadoun R. Low-level laser therapy: a standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients? Laser Ther 2012; 21(4):297-303. https://doi.org/10.5978/islsm.12-RE-01

Gobbo M, Merigo E, Arany PR, Bensadoun RJ, Santos-Silva AR, Gueiros LA, et al. Quality assessment of PBM protocols for oral complications in head and neck cancer patients: Part 1. Front Oral Health 2022; 3:945718. https://doi.org/10.3389/froh.2022.945718

Gobbo M, Verzegnassi F, Ronfani L, Zanon D, Melchionda F, Bagattoni S, et al. Multicenter randomized, double-blind controlled trial to evaluate the efficacy of laser therapy for the treatment of severe oral mucositis induced by chemotherapy in children: laMPO RCT. Pediatr Blood Cancer 2018; 65(8):e27098. https://doi.org/10.1002/pbc.27098

Salvador DRN, Soave DF, Sacono NT, de Castro EF, Silva GBL, E Silva LP, et al. Effect of photobiomodulation therapy on reducing the chemo-induced oral mucositis severity and on salivary levels of CXCL8/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic stem cell transplantation: A randomized clinical trial. Lasers Med Sci 2017; 32(8):1801-1810. https://doi.org/10.1007/s10103-017-2263-1

Martins AFL, Nogueira TE, Morais MO, Oton-Leite AF, Valadares MC, Batista AC, et al. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: A study protocol for a cost-effectiveness randomized clinical trial. Trials 2019; 20(1):97. https://doi.org/10.1186/s13063-019-3196-8

Noirrit-Escclassan E, Valera MC, Vignes E, Munzer C, Bonal S, Daries M, et al. Photobiomodulation with a combination of two wavelengths in the treatment of oral mucositis in children: The PEDIASE feasibility study. Arch Pediatr 2019; 26(5):268-274. https://doi.org/10.1016/j.arcped.2019.05.012

Miranda-Silva W, Gomes-Silva W, Zadik Y, Yarom N, Al-Azri AR, Hong CHL, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients. Support Care Cancer 2021; 29(7):3539-3562. https://doi.org/10.1007/s00520-020-05803-4

Nunes LFM, de Arruda JA, Souza AF, Costa Silva RC, Moreira Lanza CR, Kakehasi FM, et al. Prophylactic photobiomodulation therapy using 660 nm diode laser for oral mucositis in pediatric patients under chemotherapy: 5-year experience from a Brazilian referral service. Lasers Med Sci 2020; 35(8):1857-1866. https://doi.org/10.1007/s10103-020-03060-9

Kauark-Fontes E, Rodrigues-Oliveira L, Epstein JB, Faria KM, Araújo ALD, Gueiros LAM, et al. Cost-effectiveness of photobiomodulation therapy for the prevention and management of cancer treatment toxicities: A systematic review. Support Care Cancer 2021; 29(6):2875-2884. https://doi.org/10.1007/s00520-020-05949-1

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Diretrizes metodológicas: Diretriz de Avaliação Econômica / Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia. 2. ed. Brasília: Ministério da Saúde; 2014. 132 p. [In Portuguese].

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health 2013; 16(2):231-250. https://doi.org/10.1016/j.jval.2013.02.002

Chaudhry HM, Bruce AJ, Wolf RC, Litzow MR, Hogan WJ, Patnaik MS, et al. The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: A systematic review. Biol Blood Marrow Transplant 2016;22(4):605-616. https://doi.org/10.1016/j.bbmt.2015.09.014

Wuketich S, Hienz SA, Marosi C. Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors. Support Care Cancer 2012; 20(1):175-183. https://doi.org/10.1007/s00520-011-1107-y

Farias Gabriel A, Silveira FM, Curra M, Schuch LF, Wagner VP, Martins MAT, et al. Risk factors associated with the development of oral mucositis in pediatric oncology patients: Systematic review and meta-analysis. Oral Dis 2022; 28(4):1068-1084. https://doi.org/10.1111/odi.13863

Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity, and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66(3):253-262. https://doi.org/10.1016/s0167-8140(02)00404-8

Dutra LMRF, Araújo AM, Alves BLP, Santos EJF. Analysis of adverse reactions to chemotherapy in onco-hematologic patients. Braz J Dev 2022; 8(7):51362-51384. https://doi.org/10.34117/bjdv8n7-178 [In Portuguese].

Barrach RH, Souza MP, Silva DP, Lopez PS, Montovani JC. Oral changes in individuals undergoing hematopoietic stem cell transplantation. Braz J Otorhinolaryngol 2015; 81(2):141-147. https://doi.org/10.1016/j.bjorl.2014.04.004

Pires HF, Bezerra PMM, Silva VB, Ribeiro ILA, Serpa EBM, Sousa SA, et al. Occurrence and severity of oral mucositis in Brazilian pediatric cancer patients. Pesqui Bras Odontopediatria Clin Integr 2020; 20:e5621. https://doi.org/10.1590/pboci.2020.085

Campos TM, do Prado Tavares Silva CA, Sobral APT, Sobral SS, Rodrigues MFSD, Bussadori SK, et al. Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis. Support Care Cancer 2020; 28(12):5649-5659. https://doi.org/10.1007/s00520-020-05613-8

Bezinelli LM, de Paula Eduardo F, da Graça Lopes RM, Biazevic MG, de Paula Eduardo C, Correa L, et al. Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation. Hematol Oncol 2014; 32(1):31-39. https://doi.org/10.1002/hon.2050

Lopes Martins AF, Nogueira TE, Morais MO, de Sousa-Neto SS, Oton-Leite AF, Valadares MC, et al. Cost-effectiveness randomized clinical trial on the effect of photobiomodulation therapy for prevention of radiotherapy-induced severe oral mucositis in a Brazilian cancer hospital setting. Support Care Cancer 2021; 29(3):1245-1256. https://doi.org/10.1007/s00520-020-05607-6

Jabłoński P, Musiał M, Wiench R, Stefanik N, Olchowy C, Matys J, et al. Photobiomodulation therapy in the treatment of oral mucositis - A case report. Medicine 2022; 58(5):618. https://doi.org/10.3390/medicine58050618

Vitale MC, Modaffari C, Decembrino N, Zhou FX, Zecca M, Defabianis P. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients using hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT). Lasers Med Sci 2017; 32(6):1423-1428. https://doi.org/10.1007/s10103-017-2266-y

Sousa Melo A, Andrade CL, de Lima Dantas JB, Medrado ARAP, Martins GB, Lima HR, Carrera M. Impact of photobiomodulation for oral mucositis on body weight and BMI of patients with head and neck cancer. Support Care Cancer 2022; 30(6):4897-4904. https://doi.org/10.1007/s00520-022-06899-6

Bezerra PMM, Sampaio MEA, Dos Santos FG, Ribeiro ILA, Santiago BM, de Sousa SA, et al. The effectiveness of an oral health education and prevention program on the incidence and severity of oral mucositis in pediatric cancer patients: a non-randomized controlled study. Support Care Cancer 2021; 29(12):7877-7885. https://doi.org/10.1007/s00520-021-06387-3